Synergy CHC Corp. Sales and Excise Tax Payable
Synergy CHC Corp. (SNYR) had Sales and Excise Tax Payable of $1.15 thousand as of 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Balance Sheet › Liabilities
us-gaap:SalesAndExciseTaxPayableCurrentAndNoncurrent · last filed 2026-05-14
- 2026-03-31: Sales and Excise Tax Payable $1.15K.
- 2025-12-31: Sales and Excise Tax Payable $355.00.
- 2025-09-30: Sales and Excise Tax Payable $2.57K.
- 2025-06-30: Sales and Excise Tax Payable $3.42K.
| Period end | Sales and Excise Tax Payable |
|---|---|
| 2026-03-31 | $1.15K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $355.00 10-Q · filed 2026-05-14 |
| 2025-09-30 | $2.57K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $3.42K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $4.79K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $3.70K 10-K · filed 2026-04-01 |
| 2024-09-30 | $2.89K 10-Q · filed 2024-12-06 |
| 2023-12-31 | $6.10K 10-K · filed 2025-03-31 |
| 2020-03-31 | $245.72K 10-Q · filed 2020-06-29 |
| 2019-12-31 | $273.86K 10-K · filed 2020-04-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |